Page last updated: 2024-10-27

fluorouracil and Koch's Disease

fluorouracil has been researched along with Koch's Disease in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, XW1
Ren, LL1
Zhang, YW1
Yin, WJ1
Tao, G1
Xin, WX1
Chen, ZJ1
Huang, P1
Feng, CG1
Weksberg, DC1
Taylor, GA1
Sher, A1
Goodell, MA1

Other Studies

2 other studies available for fluorouracil and Koch's Disease

ArticleYear
Subcutaneous tuberculosis formation during FOLFIRI and bevacizumab treatment: a case report.
    International journal of colorectal disease, 2016, Volume: 31, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Female; Fluorourac

2016
The p47 GTPase Lrg-47 (Irgm1) links host defense and hematopoietic stem cell proliferation.
    Cell stem cell, 2008, Jan-10, Volume: 2, Issue:1

    Topics: Animals; Flow Cytometry; Fluorouracil; Gene Expression Regulation; GTP-Binding Proteins; Hematopoies

2008